Dare Bioscience (DARE)
(Delayed Data from NSDQ)
$3.18 USD
-0.07 (-2.15%)
Updated Oct 3, 2024 03:57 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.60 |
EPS Last Quarter | 1.52 |
Last EPS Surprise | 366.67% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.27 |
Next Year | -1.00 |
EPS (TTM) | -1.12 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.09M | 4.19M | 3.67M | 59.50M |
# of Estimates | 1 | 1 | 2 | 1 |
High Estimate | 3.09M | 4.19M | 7.31M | 59.50M |
Low Estimate | 3.09M | 4.19M | 0.03M | 59.50M |
Year ago Sales | 1.00M | 1.81M | 2.81M | 3.67M |
Year over Year Growth Est. | 209.00% | 131.49% | 30.70% | 1,521.25% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.60 | -0.39 | -0.27 | -1.00 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -0.66 | -0.26 | -0.27 | -1.00 |
High Estimate | -0.54 | -0.26 | -0.20 | -1.00 |
Low Estimate | -0.66 | -0.52 | -0.33 | -1.00 |
Year ago EPS | -1.08 | -0.72 | -4.20 | -0.27 |
Year over Year Growth Est. | 44.44% | 45.83% | 93.57% | -272.22% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.60 | -0.39 | -0.27 | -1.00 |
7 Days Ago | -0.60 | -0.39 | -0.27 | -1.00 |
30 Days Ago | -0.60 | -0.39 | -0.27 | -1.00 |
60 Days Ago | -0.69 | -0.50 | -2.57 | 1.32 |
90 Days Ago | -0.69 | -0.50 | -2.57 | 1.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.60 | -0.39 | -0.27 | -1.00 |
Zacks Consensus Estimate | -0.60 | -0.39 | -0.27 | -1.00 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.52 | -0.84 | -0.72 | -1.08 | NA |
Estimate | -0.57 | -0.72 | -1.44 | -1.20 | NA |
Difference | 2.09 | -0.12 | 0.72 | 0.12 | 0.70 |
Surprise | 366.67% | -16.67% | 50.00% | 10.00% | 102.50% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more